Teleflex

American medical device company

TFX NYSE ISIN US8793691069 SEC CIK 96943 LEI UUL85LWXB4NGSWWXIQ25
Follow Teleflex Weekly email: filings, results

Financials

Reported figures only · latest: Q3 2026 USD · US GAAP
Revenue, last quarter $567.8M +0.1% vs same quarter last year
Net income $927.4M +326.8% vs same quarter last year
EPS, diluted $22.28 +341.1% vs same quarter last year
Operating cash flow $96.3M +392.1% vs same quarter last year
Revenue by quarter
$442M
$414.3M
$442.5M
$566.9M
$569M
$548.3M
$570.3M
$567.8M
Q4 24 Q1 25 Q2 25 Q3 25 Q4 25 Q1 26 Q2 26 Q3 26

Source: SEC XBRL filings · latest filing

The long view

Fiscal years as reported · SEC XBRL filings, US GAAP
Revenue and net income15 fiscal years
  • Revenue
  • Net income
−$1B$0$1B$2B$3BFY11FY13FY15FY17FY19FY21FY23FY25
Show the numbers
YearRevenueNet income
FY25$2B−$905.6M
FY24$1.7B$70.2M
FY23$1.7B$357.6M
FY22$2.8B$363.1M
FY21$2.8B$485.4M
FY20$2.5B$335.3M
FY19$2.6B$461.5M
FY18$2.4B$200.8M
FY17$2.1B$152.5M
FY16$1.9B$237.4M
FY15$1.8B$244.9M
FY14$1.8B$187.7M
FY13$1.7B$150.9M
FY12$1.6B−$190.1M
FY11$1.5B$323.3M
MarginsShare of revenue
  • Gross margin
  • Operating margin
  • Net margin
−50%0%50%100%FY11FY13FY15FY17FY19FY21FY23FY25
Show the numbers
YearGross marginOperating marginNet margin
FY2556.2%5.9%−45.4%
FY2461%6.1%4.1%
FY2360.7%15.1%20.9%
FY2254.9%17.9%13%
FY2155.2%22.4%17.3%
FY2052.2%16.7%13.2%
FY1954.3%16.5%17.8%
FY1853.2%13.1%8.2%
FY1754.6%17.3%7.1%
FY1653.3%17.1%12.7%
FY1552.2%17.5%13.5%
FY1451.2%15.5%10.2%
FY1349.5%13.8%8.9%
FY1248.2%−6.3%−12.3%
FY1147.5%15.4%21.7%
Free cash flowOperating cash flow minus capital expenditure
$0$200M$400M$600MFY11FY13FY15FY17FY19FY21FY23FY25
Show the numbers
YearFree cash flow
FY25$1.4M
FY24$211.4M
FY23$159.7M
FY22$263.6M
FY21$580.5M
FY20$346.4M
FY19$334.4M
FY18$354.3M
FY17$355.4M
FY16$357.5M
FY15$242M
FY14$222.7M
FY13$167.7M
FY12$129.2M
FY11$49.8M
Returned to shareholdersDividends paid and shares bought back
  • Dividends
  • Buybacks
$0$100M$200M$300M$400MFY11FY13FY15FY17FY19FY21FY23FY25
Show the numbers
YearDividendsBuybacks
FY25$60.3M$300M
FY24$63.5M$200M
FY23$63.9M$0
FY22$63.8M$0
FY21$63.6M-
FY20$63.2M-
FY19$62.8M-
FY18$62.2M-
FY17$61.2M-
FY16$59M-
FY15$56.5M-
FY14$56.3M-
FY13$55.9M-
FY12$55.6M-
FY11$55.1M-
Net margin vs the sectorMedian of Healthcare companies filing with the SEC
  • Teleflex
  • Healthcare median
−100%−50%0%50%FY11FY13FY15FY17FY19FY21FY23FY25
Show the numbers
YearTeleflexHealthcare median
FY25−45.4%−30.6%
FY244.1%−47%
FY2320.9%−58%
FY2213%−80.4%
FY2117.3%−71.9%
FY2013.2%−62.2%
FY1917.8%−46.3%
FY188.2%−49.6%
FY177.1%−45.9%
FY1612.7%−36%
FY1513.5%−38.4%
FY1410.2%−35.5%
FY138.9%−37.1%
FY12−12.3%−29.1%
FY1121.7%−27.9%